RESULTS	Of the remaining 276 patients , TAA were observed in 43 ( 44.8 % ) of 96 patients in Group A , 28 ( 29.5 % ) of 95 patients in Group B and 62 ( 72.9 % ) of 85 patients in Group C. TAA were significantly less in A and B groups than in Group C ( p < 0.005 ) ; a significant TAA reduction was also observed in patients treated with sotalol compared with those treated with propafenone ( p < 0.05 ) .\